Clinical Trials Directory

Trials / Completed

CompletedNCT00985361

Effect of Vitamin D Supplementation on Hemoglobin A1c in Patients With Uncontrolled Type 2 Diabetes Mellitus

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
37 (actual)
Sponsor
ProMedica Health System · Academic / Other
Sex
All
Age
21 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine if daily supplementation with 2000 International Units of Vitamin D will improve hemoglobin A1c in uncontrolled type 2 diabetics.

Detailed description

Vitamin D is typically understood to support musculoskeletal health when administered concomitantly with calcium. A number of recent studies suggest, however, that this important nutrient may play a significant role in many pathophysiological processes, including diabetes mellitus. With the prevalence of diabetes mellitus ever increasing, novel mechanisms for controlling blood glucose and hemoglobin A1c are being sought to help prevent the costly and debilitating complications of this chronic disease.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTVitamin D3 2000 international units dailyVitamin D3 2000 international unit tablets once daily for 3 months
DIETARY_SUPPLEMENTVitamin C 500mg dailyVitamin C 500mg tablets once daily for 3 months

Timeline

Start date
2009-10-01
Primary completion
2010-03-01
Completion
2010-03-01
First posted
2009-09-28
Last updated
2010-05-06

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00985361. Inclusion in this directory is not an endorsement.